Medical News

RSS

Level of bacteria on fresh produce can vary according to income level: Study

No one wants a mixed salad tossed with extra bacteria, mold and yeast, but those are just what you might find when you try to eat a healthier diet in poorer neighborhoods. A new study shows that the level of bacteria found on the fresh produce can vary according to the income level of the neighborhoods where it is for sale.

9 Apr 2010

World Vision to construct transitional shelters for displaced Haitians

World Vision is supporting the first relocation of 7,500 displaced Haitians from camps in Port-au-Prince to a site on the outskirts of the city where transitional shelters will be built. In partnership with other agencies, World Vision will construct one-third of the 1,356 shelters planned for a 75 sq. kilometre plot of land recently allocated by the Government of Haiti for people most at risk from the upcoming rainy season.

9 Apr 2010

The Kids Food Adventure with Chef Jehangir Mehta created to promote positive eating habits for children

Whole Foods Market, the leading natural and organic foods supermarket, and Chef Jehangir Mehta, "The Next Iron Chef" runner-up and executive chef/owner of Graffiti Food & Wine Bar in New York City, have joined forces to create The Kids Food Adventure with Chef Jehangir Mehta, a series of hands-on classes to encourage parents and children to be more adventurous with food while making healthy choices.

9 Apr 2010

Catalyst Pharmaceutical Partners' vigabatrin data to be presented at 41st ASAM conference

Catalyst Pharmaceutical Partners, Inc. today announced that on Friday April 16th, Eugene C. Somoza, MD, PhD, University of Cincinnati College of Medicine and VA Medical Center, Cincinnati, OH will present a paper he authored along with Charles Gorodetzky, MD, PhD, Douglas Winship and Peggy Somoza, entitled: "A Multi-Site, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Vigabatrin (VGB) for Treating Cocaine Dependence"

9 Apr 2010

TriLink partners with Cedarlane to enhance distribution of its products in Canada

TriLink BioTechnologies, has entered into an agreement with Cedarlane Corporation, a Canadian based research biotechnology company, for the sale and distribution of its modified nucleoside triphosphates, custom chemistry and oligonucleotide products.

9 Apr 2010

Cephalon acquires Mepha

Cephalon, Inc. announced that it has today completed its previously announced acquisition of Mepha, the Swiss-based pharmaceutical company. As a result of the acquisition, Mepha is now a wholly-owned subsidiary of Cephalon. The purchase price paid at closing, inclusive of certain closing adjustments, was CHF 662.4 million (or approximately US$615.4 million). The purchase price is also subject to further post-closing working capital and net debt adjustments.

9 Apr 2010

KHN Column: Can Massachusetts' experiment tell us what's next?

In his latest Kaiser Health News column, James Capretta writes: "Now that the year-long debate in Congress over health care legislation has come to a close, it's reasonable to ask: What's next?"

9 Apr 2010

Penwest Pharmaceuticals signs drug development and commercialization agreement with Alvogen

Penwest Pharmaceuticals Co. today announced that it has signed a drug development and commercialization agreement with Alvogen, Inc. under which Penwest and Alvogen have agreed to identify and select up to five compounds for generic development. Penwest's TIMERx technology may be used for each compound selected.

9 Apr 2010

More public-private partnerships crucial for success of Italian pharmaceutical industry

The newly retired Chief Executive Officer of Roche Pharmaceuticals Bill Burns today led calls for more public-private partnerships in the pharmaceutical industry at the launch of the Italian Institute of Technology's Drug Discovery and Development Unit (D3).

9 Apr 2010

Hospitalists shape the future of American healthcare system

On March 21, 2010, Congress passed the most comprehensive healthcare reform bill since the formation of Medicare. While a monumental achievement, the bill leaves much of the critical work of healthcare reform unfinished, according to a new editorial by Dr. Robert Wachter, Chief of the Division of Hospital Medicine, University of California, San Francisco, and past president of the Society of Hospital Medicine, in the April issue of the Journal of Hospital Medicine.

9 Apr 2010

Tβ4 therapy for ocular disorders closer to reality

RegeneRx Biopharmaceuticals, Inc. announced today that Tβ4, a synthetic version of a naturally occurring peptide that is the basis for the company's product candidates, will be the subject of three poster presentations at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to be held in Fort Lauderdale, Florida from May 2-6, 2010.

9 Apr 2010

Broken heart disease affects women in post menopause period

It seems an infarction, but it's not. It's called Tako-Tsubo syndrome, or stress-induced cardiomyopathy, and it's a rare disease which at first used to be confused with the far more common (and dangerous) cardiac infarction. Patients arrive to the emergency room with the characteristic heart attack symptoms: acute pain in the chest, an electrocardiogram with the typical changes and the release of those enzymes associated with the usual heart disease.

9 Apr 2010

A*STAR announces fifth major collaboration with Italian research centres and universities

Two research units under Singapore's Agency for Science, Technology and Research (A*STAR), the Experimental Therapeutics Centre (ETC) and Singapore Immunology Network (SIgN), are collaborating with Italy's Siena Biotech S.p.A. to develop new drugs and targeted antibodies respectively, which will potentially help millions of cancer and bone loss patients across the world. This is the fifth major collaboration A*STAR has with research centres and universities in Italy .

9 Apr 2010

BIBA Research's TAVI report to be released

BIBA Research, the UK-based market research specialists for the medical technology industry, announced today that the latest findings from their Transcatheter Heart Valve report will be released on 26 April. The report covers the data period January-March 2010 and is part of BIBA Research's long-established European Cardiovascular Monitor.

9 Apr 2010

Gelatinase B expression enhanced in gastric cancer compared to normal gastric mucosa

Gastric cancer in Mexico is the most frequent gastrointestinal malignant neoplasm. Several precursor conditions, such as chronic gastritis, have been associated with the development of gastric cancer. The gelatinases MMP-2 and MMP-9, members of the metalloproteinase family, are fundamental enzymes in extracellular matrix remodelling. The extracellular matrix is composed of secreted molecules outside cells which provides structural support and regulates cell behaviour.

9 Apr 2010

State Department to open new hunger, food security office

The Department of State on Wednesday announced it is opening a "new office on hunger and food security," Politico's Laura Rozen writes on her blog.

9 Apr 2010

ONA supports government's concern about rising costs of pharmaceuticals

Noting that Ontario already spends 10.7 per cent more on drugs per capita than other provinces, the Ontario Nurses' Association is pleased that the government is turning its attention to reducing provincial drug costs.

9 Apr 2010

WebMD Health announces preliminary results of 5.8M common stock tender offer

WebMD Health Corp. announced today the preliminary results of its tender offer to purchase up to 5,800,000 shares of its common stock at a price of $46.80 per share, which expired at 5:00 p.m., New York City time on April 8, 2010.

9 Apr 2010

RED BOOK Drug References continue to provide current pricing, product information on drugs

Some vendors have announced they will stop publishing the Average Wholesale Price of drugs in 2011, but Thomson Reuters will continue to supply this needed information in RED BOOK.

9 Apr 2010

Effective compound against antibiotic-resistant biofilms

Researchers at North Carolina State University have found a chemical compound that, when used in conjunction with conventional antibiotics, is effective in destroying biofilms produced by antibiotic-resistant strains of bacteria such as the Staphylococcus strain MRSA and Acinetobacter. The compound also re-sentsitizes those bacteria to antibiotics.

9 Apr 2010

Medical News

Level of bacteria on fresh produce can vary according to income level: Study

World Vision to construct transitional shelters for displaced Haitians

The Kids Food Adventure with Chef Jehangir Mehta created to promote positive eating habits for children

Catalyst Pharmaceutical Partners' vigabatrin data to be presented at 41st ASAM conference

TriLink partners with Cedarlane to enhance distribution of its products in Canada

Cephalon acquires Mepha

KHN Column: Can Massachusetts' experiment tell us what's next?

Penwest Pharmaceuticals signs drug development and commercialization agreement with Alvogen

More public-private partnerships crucial for success of Italian pharmaceutical industry

Hospitalists shape the future of American healthcare system

Tβ4 therapy for ocular disorders closer to reality

Broken heart disease affects women in post menopause period

A*STAR announces fifth major collaboration with Italian research centres and universities

BIBA Research's TAVI report to be released

Gelatinase B expression enhanced in gastric cancer compared to normal gastric mucosa

State Department to open new hunger, food security office

ONA supports government's concern about rising costs of pharmaceuticals

WebMD Health announces preliminary results of 5.8M common stock tender offer

RED BOOK Drug References continue to provide current pricing, product information on drugs

Effective compound against antibiotic-resistant biofilms

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News